Neuroblastoma Treatment Drugs market size is estimated to be worth US$ 966 million in 2022 and is forecast to a readjusted size of US$ 1278 million by 2028 with a CAGR of 7% during the forecast period 2022-2028. Neuroblastoma (NB) is the most common cancer in childhood and infancy. Most children with neuroblastoma are diagnosed […]
